(Q38044756)

27 August 2017

title

Genetics and the impact on treatment protocols in patients with rheumatoid arthritis (English)

1 reference

27 August 2017

1 reference

3

1 reference

27 August 2017

Ibrahim Ibrahim

1

1 reference

27 August 2017

Sally-Anne Owen

series ordinal

2

1 reference

27 August 2017

publication date

1 August 2012

1 reference

Expert Review of Clinical Immunology

27 August 2017

published in

1 reference

27 August 2017

volume

8

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

509-511

1 reference

Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity

27 August 2017

cites work

1 reference

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis

21 January 2018

1 reference

Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis

21 January 2018

1 reference

Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis.

21 January 2018

1 reference

Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis

21 January 2018

1 reference

Genetic and genomic predictors of anti-TNF response

21 January 2018

1 reference

TPMT testing in rheumatology: any better than routine monitoring?

21 January 2018

1 reference

Functional characterization of 23 allelic variants of thiopurine S-methyltransferase gene (TPMT*2 - *24).

21 January 2018

1 reference

Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?

21 January 2018

1 reference

Pharmacogenetics: implications for therapy in rheumatic diseases

21 January 2018

1 reference

Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine

21 January 2018

1 reference

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

21 January 2018

1 reference

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

21 January 2018

1 reference

Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis

21 January 2018

1 reference

The soluble biomarker calprotectin (an S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab

21 January 2018

1 reference

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

21 January 2018

1 reference

Predictors of response to anti-TNF- therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

21 January 2018

1 reference

Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: Results from a large observational inception study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECI.12.51

1 reference

27 August 2017

1 reference